HealthTree News

April 24, 2025

Paris Jones shares his experience with multiple myeloma, from the onset of symptoms to life after diagnosis

April 24, 2025

Research shows U.S. service members have higher MGUS rates, a myeloma precursor. Learn what veterans should know about screening and specialized care access.

April 23, 2025

xplore our new HealthTree University unit on disparities in myeloma care. Learn about health equity, clinical trials, and self-advocacy for better outcomes.

April 22, 2025

Celebrate National Volunteer Month by joining a Regional Cure Team. Make a difference in the blood cancer community through advocacy, support, and outreach.

April 22, 2025

New study reveals how men and women with relapsed/refractory multiple myeloma differ in treatment decision-making factors, preferences, and information sources.

April 17, 2025

Blenrep is back. Learn why its approval in the UK matters for relapsed myeloma patients worldwide and what new trial results reveal about its potential.

April 17, 2025

Living with chronic blood cancer but feel unseen or misunderstood? You're not alone. Find support, tools, and validation here.

April 16, 2025

HealthTree survey results show that patients can flourish and find deeper meaning in their lives following a cancer diagnosis

April 16, 2025

Understanding how ROR1-targeted therapies work—and whether they apply to your specific blood cancer type—can help you make more informed treatment decisions.

April 15, 2025

Learn about two promising new drug classes for relapsed/refractory multiple myeloma: Lisaftoclax and inobrodib work differently from standard treatments.